| |
|
|
|
Celldex Therapeutics- Inc.  
|
|
0.5891 -0.005 (-0.01%) |
06-19 16:00 |
|
Open: |
0.6 |
Pre close: |
0.5945 |
Target:
|
0.79 
|
|
High: |
0.6037 |
Low: |
0.589 |
Resistance:
|
0.67
0.73
|
|
Volume: |
3,570,292 |
Market Cap: |
84M |
Support:
|
0.58
0.48
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.59
|
MACD |
MACD(12,26):
|
-0.07  |
|
MA(20): |
0.62 |
Signal(12,26,9): |
-0.09 |
|
MA(100): |
1.62 |
Stochastic Oscillator |
%K(14,3):
|
5.79 |
|
MA(250): |
2.26 |
%D(3): |
9.00 |
|
Average Volume(K) |
3-Month: |
360437
|
52-Week |
High:
|
3.26 |
|
10-Days: |
302186 |
Low: |
0.58 |
|
RSI |
RSI(14):
|
29.83 |
Change(%): |
-76.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.730 |
Return on Equity (ttm) |
-84.1 |
Shares Out. (M) |
143.39 |
|
EPS Est. Current Year |
-1.040 |
Return on Assets (ttm) |
-58.2 |
Shares Float (M) |
136.77 |
|
EPS Est. Next Year |
-0.950 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.280 |
Qtrly Rev. Growth |
165.2 |
% Held by Institutions |
43.90 |
|
Forward EPS |
-0.818 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
8586 |
|
Book Value (p.s.) |
0.640 |
EBITDA (p.s.) |
-0.407 |
P/E |
-0.81 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.92 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-92.69 |
P/S |
703925376.00 |
|
Operating Margin |
-662.69 |
Levered Free Cash Flow
(M) |
-53.01 |
P/CF |
-0.91 |
|
|
|
|
|
|
